# A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026

> **NCT07900139** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 1 (estimated)

## Conditions studied

- COVID-19 SARS-CoV-2 Infection

## Interventions

- **OTHER:** Patients with COVID-19

## Key facts

- **NCT ID:** NCT07900139
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-07-20
- **Primary completion:** 2026-10-30
- **Final completion:** 2026-10-30
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2026-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07900139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07900139, "A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07900139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
